Olmesartan Medoxomil/Hct Cf (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil/Hct Cf, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is used in adult patients. GNH USA supplies Olmesartan Medoxomil/Hct Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil/Hct Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil/hydrochlorothiazide is used for managing blood pressure through the renin‑angiotensin system and diuretic pathways.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure with reduced ejection fraction: assists in fluid management and blood pressure control. - Diabetic nephropathy: helps slow progression by controlling hypertension. - Chronic kidney disease stage 3–4: provides blood pressure control when combined with a diuretic. - Post‑myocardial infarction: contributes to secondary prevention of cardiovascular events.

Common Side Effects: - Dizziness : light‑dof   -       ...

Serious or Rare Side Effects: -  .... -  ...  

Olmesartan medoxomil/   g   g …  

---